Cite
HARVARD Citation
D'agostino, G. et al. (2006). A multicenter phase II study of the cryptophycin analog LY355703 in patients with platinum-resistant ovarian cancer. International journal of gynecological cancer. 16 (1), pp. 71-76. [Online].